Executing Concurrent Decentralized RCTs And RWE At Scale

Validating that digital care for musculoskeletal conditions can match or outperform traditional in-person treatment requires rigorous, large-scale evidence. However, executing high-precision randomized controlled trials (RCTs) often presents significant operational hurdles, including protocol complexity, operational burdens, and deployment agility challenges. For lean clinical research teams, these technical bottlenecks can stall aggressive timelines and limit the ability to generate meaningful real-world evidence (RWE).

By adopting Castor's unified, low-code platform that integrates electronic data capture (EDC), ePRO, and eConsent, researchers can bypass traditional vendor delays and maintain total control over their study builds. This flexible approach supports the simultaneous execution of complex RCTs and high-volume, longitudinal RWE cohorts. The results of this strategy are transformative. The insights demonstrated here reveal how prioritizing usability and scalability allows small teams to deliver massive, audit-ready evidence engines that redefine clinical standards.